ISSCR Consortium Urges FDA to Maintain Flexible, Science-Driven Framework for New Approach Methodologies in Drug Development
May 21, 2026
May 21, 2026
EVANSTON, Illinois, May 21 -- The International Society for Stem Cell Research issued the following news release:
* * *
ISSCR Consortium Urges FDA to Maintain Flexible, Science-Driven Framework for New Approach Methodologies in Drug Development
The International Society for Stem Cell Research (ISSCR) Consortium on Advanced Stem Cell-Based Models in Drug Discovery and Development has submitted comments to the U.S. Food and Drug Administration (FDA) in respon . . .
* * *
ISSCR Consortium Urges FDA to Maintain Flexible, Science-Driven Framework for New Approach Methodologies in Drug Development
The International Society for Stem Cell Research (ISSCR) Consortium on Advanced Stem Cell-Based Models in Drug Discovery and Development has submitted comments to the U.S. Food and Drug Administration (FDA) in respon . . .
